Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Recombinant Human Leptin Therapy Effects on Insulin Action

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01207934
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:35:53.448622+00:00
Published At
2011-08-10T00:00:00+00:00
Record Updated At
2015-07-09
Results Posted At
2011-08-10
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Type Two Diabetes Mellitus"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2015-07-09"
protocolSection.identificationModule.nctId
"NCT01207934"
protocolSection.identificationModule.officialTitle
"Recombinant Human Leptin Therapy Effects on Insulin Action"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2011-08-10"

Study condition terms

  • Type Two Diabetes Mellitus (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.